Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asahi Kasei
Pharma
Asahi Kasei's CDMO Bionova branches out into plasmid DNA
Asahi Kasei's CDMO Bionova is expanding its offerings to include starting materials for innovative medicines such as cell and gene therapies.
Fraiser Kansteiner
Jun 3, 2024 11:36am
Takeda, Daiichi Sankyo, Asahi Kasei—Fierce Pharma Asia
May 31, 2024 10:48am
Asahi Kasei moves to buy Calliditas for more than $1B
May 28, 2024 11:19am
Bionova Scientific plans plant expansion at California facility
Feb 2, 2023 9:40am
Merck, Sanofi, Fujifilm and more—Fierce Pharma Asia
Apr 22, 2022 8:42am
Asahi Kasei acquires CDMO Bionova for undisclosed price
Apr 19, 2022 10:40am
